Jean-Pierre Sommadossi | Founder & CEO |
Janet Hammond | Chief Development Officer |
Andrea Corcoran | CFO & EVP, Legal |
John Vavricka | Chief Commercial Officer |
Jonae Barnes | SVP, IR & Corporate Communications |
Hannah Colgan | JPMorgan |
Umer Raffat | Evercore |
Nik Gasic | SVB Securities |
Jonathan Miller | Evercore |
Good morning, and welcome to the Atea Pharmaceuticals First Quarter 2022 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode to prevent any background noise. And following management’s prepared remarks, the call will be opened for your questions. [Operator instructions]. Please be advised that today’s call is being recorded.